Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer


Por: Torrecilla, JL, Zapatero, A, Herruzo, I, Calvo, FA, Cabeza, MA, Palacios, A, Guerrero, A, Hervas, A, Lara, P, Martinez, BL, Penalver, ED, Nagore, G, Sancho, G, Mengual, JL, Mira, M, Mairino, A, Samper, P, Perez, S, Castillo, I, Cedres, JCM, Ferrer, E, Rodriguez, S, Maldonado, X, Caamano, AG, Ferrer, C

Publicada: 1 may 2014
Resumen:
The purpose of the study was to describe infrastructures, treatment modalities, and workload in radiation oncology (RO) in Spain, referred particularly to prostate cancer (PC). An epidemiologic, cross-sectional study was performed during 2008-2009. A study-specific questionnaire was sent to the 108 RO-registered departments. One hundred and two departments answered the survey, and six were contacted by telephone. Centers operated 236 treatment units: 23 (9.7 %) cobalt machines, 37 (15.7 %) mono-energetic linear accelerators, and 176 (74.6 %) multi-energy linear accelerators. Sixty-one (56.4 %) and 33 (30.5 %) departments, respectively, reported intensity-modulated radiation therapy (IMRT) and image-guided RT (IGRT) capabilities; three-dimensional-conformal RT was used in 75.8 % of patients. Virtual simulators were present in 95 departments (88.0 %), 35 use conventional simulators. Fifty-one departments (47.2 %) have brachytherapy units, 38 (35.2 %) perform prostatic implants. Departments saw a mean of 24.9 new patients/week; the number of patients treated annually was 102,054, corresponding to 88.4 % of patients with a RT indication. In 56.5 % of the hospitals, multidisciplinary teams were available to treat PC. Results provide an accurate picture of current situation of RO in Spain, showing a trend toward the progressive introduction of new technologies (IMRT, IGRT, brachytherapy).

Filiaciones:
Torrecilla, JL:
 Hosp Gen Univ, ERESA, Dept Radiat Oncol, Avda Tres Cruces 2, Valencia 46007, Spain

Zapatero, A:
 Hosp Univ Princesa, Dept Radiat Oncol, Madrid 28006, Spain

Herruzo, I:
 Hosp Univ Carlos Haya, Dept Radiat Oncol, Malaga 29010, Spain

Calvo, FA:
 Hosp Univ Gregorio Maranon, Dept Oncol, Madrid 28009, Spain

Cabeza, MA:
 Univ Hosp, Madrid 28041, Spain

Palacios, A:
 Hosp Univ Reina Sofia, Cordoba 14004, Spain

Guerrero, A:
 Hosp Univ Son Dureta, Palma De Mallorca 07014, Spain

Hervas, A:
 Hosp Univ Ramon & Cajal, Madrid 28034, Spain

Lara, P:
 Hosp Univ Gran Canaria Dr Negrin, Las Palmas Gran Canaria, Spain

Martinez, BL:
 Hosp Univ Fuenlabrada, Fuenlabrada 28942, Spain

Penalver, ED:
 Hosp Quiron Madrid, Madrid 28006, Spain

Nagore, G:
 Sanatorio Perpetuo Socorro, IMO, Inst Alicantino, Oncol Grp, Alicante 03013, Spain

Sancho, G:
 Hosp Santa Creu & Sant Pau, Barcelona 08026, Spain

Mengual, JL:
 Inst Valenciano Oncol, Valencia 46009, Spain

Mira, M:
 Hosp Arnau Vilanova, Lleida 25198, Spain

Mairino, A:
 Complejo Hosp Univ A Coruna, Ctr Oncol Galicia, La Coruna 15009, Spain

Samper, P:
 Hosp Cent Defensa Gomez Ulla, Madrid 28047, Spain

Perez, S:
 Hosp Marquees Valdecilla, Santander 39008, Spain

Castillo, I:
 Univ San Cecilio, Hosp Clin, Granada 18012, Spain

Cedres, JCM:
 Hosp Univ Nuestra Senora Candelaria, Tenerife 38010, Spain

Ferrer, E:
 Univ Valencia, Hosp Clin, Valencia 46010, Spain

Rodriguez, S:
 Hosp Clin Benidorm, Benidorm 03501, Spain

Maldonado, X:
 Hosp Valle De Hebron, Barcelona 08035, Spain

Caamano, AG:
 Univ Santiago Compostela, Hosp Clin, Santiago De Compostela 15706, Spain

Ferrer, C:
 Consorcio Hosp Prov Castellon, Castellon de La Plana 12002, Spain
ISSN: 1699048X





Clinical & Translational Oncology
Editorial
SPRINGER INTERNATIONAL PUBLISHING AG, GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND, España
Tipo de documento: Article
Volumen: 16 Número: 5
Páginas: 447-454
WOS Id: 000334432100003
ID de PubMed: 24682792

MÉTRICAS